90 related articles for article (PubMed ID: 1713115)
1. Parachloroamphetamine selectively alters regional cerebral metabolic responses to the serotonergic agonist metachlorophenylpiperazine in rats.
Freo U; Larson DM; Tolliver T; Rapoport SI; Soncrant TT
Brain Res; 1991 Mar; 544(1):17-25. PubMed ID: 1713115
[TBL] [Abstract][Full Text] [Related]
2. Cerebral metabolic responses to clomipramine are greatly reduced following pretreatment with the specific serotonin neurotoxin para-chloroamphetamine (PCA). A 2-deoxyglucose study in rats.
Freo U; Pietrini P; Pizzolato G; Furey M; Merico A; Ruggero S; Dam M; Battistin L
Neuropsychopharmacology; 1995 Nov; 13(3):215-22. PubMed ID: 8602894
[TBL] [Abstract][Full Text] [Related]
3. Time courses of behavioral and regional cerebral metabolic responses to different doses of meta-chlorophenylpiperazine in awake rats.
Freo U; Soncrant TT; Ricchieri GL; Wozniak KM; Larson DM; Rapoport SI
Brain Res; 1990 Mar; 511(2):209-16. PubMed ID: 2334843
[TBL] [Abstract][Full Text] [Related]
4. Cerebral metabolic responses to meta-chlorophenylpiperazine are reduced during its chronic administration to young and aged rats.
Freo U; Larson DM; Soncrant TT
Gerontology; 1993; 39(6):305-13. PubMed ID: 8144044
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.
Freo U; Holloway HW; Greig NH; Soncrant TT
Psychopharmacology (Berl); 1992; 107(1):30-8. PubMed ID: 1534179
[TBL] [Abstract][Full Text] [Related]
6. Age-related alterations in behavioral and cerebral metabolic responses to the serotonin agonist meta-chlorophenylpiperazine in rats.
Freo U; Rapoport SI; Soncrant TT
Neurobiol Aging; 1991; 12(2):137-44. PubMed ID: 2052128
[TBL] [Abstract][Full Text] [Related]
7. Time- and dose-dependent effects of the serotonergic agent quipazine on regional cerebral metabolism in rats.
Freo U; Ricchieri GL; Holloway HW; Soncrant TT
Brain Res; 1993 Jan; 600(2):249-56. PubMed ID: 8435750
[TBL] [Abstract][Full Text] [Related]
8. Brain-to-blood partition and in vivo inhibition of 5-hydroxytryptamine reuptake and quipazine-mediated behaviour of nefazodone and its main active metabolites in rodents.
Nacca A; Guiso G; Fracasso C; Cervo L; Caccia S
Br J Pharmacol; 1998 Dec; 125(7):1617-23. PubMed ID: 9884092
[TBL] [Abstract][Full Text] [Related]
9. Adrenalectomy or metyrapone-pretreatment abolishes cerebral metabolic responses to the serotonin agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the hippocampus.
Freo U; Holloway HW; Kalogeras K; Rapoport SI; Soncrant TT
Brain Res; 1992 Jul; 586(2):256-64. PubMed ID: 1521159
[TBL] [Abstract][Full Text] [Related]
10. Cerebral metabolic effects of serotonin drugs and neurotoxins.
Freo U
Life Sci; 1996; 59(11):877-91. PubMed ID: 8795699
[TBL] [Abstract][Full Text] [Related]
11. The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats.
Freo U; Pietrini P; Dam M; Pizzolato G; Battistin L
Psychopharmacology (Berl); 1993; 113(1):53-9. PubMed ID: 7862829
[TBL] [Abstract][Full Text] [Related]
12. Partial denervation of the locus coeruleus projections by treatment with the selective neurotoxin DSP-4 potentiates the long-term effect of parachloroamphetamine on 5-hydroxytryptamine metabolism in the rat.
Eller M; Harro J
Neurosci Lett; 2002 Mar; 322(1):53-6. PubMed ID: 11958842
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the binding sites for 123I-ADAM and the relationship to the serotonin transporter in rat and mouse brains using quantitative autoradiography.
Lin KJ; Yen TC; Wey SP; Hwang JJ; Ye XX; Tzen KY; Fu YK; Chen JC
J Nucl Med; 2004 Apr; 45(4):673-81. PubMed ID: 15073265
[TBL] [Abstract][Full Text] [Related]
14. Increased behavioural activity of rats in forced swimming test after partial denervation of serotonergic system by parachloroamphetamine treatment.
Häidkind R; Eller M; Kask A; Harro M; Rinken A; Oreland L; Harro J
Neurochem Int; 2004 Oct; 45(5):721-32. PubMed ID: 15234115
[TBL] [Abstract][Full Text] [Related]
15. Dose- and time-dependent effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a serotonergic 5-HT2 receptor agonist, on local cerebral glucose metabolism in awake rats.
Freo U; Soncrant TT; Holloway HW; Rapoport SI
Brain Res; 1991 Feb; 541(1):63-9. PubMed ID: 2029625
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological evidence that serotonergic stimulation of prolactin secretion is mediated via the dorsal raphe nucleus.
Van de Kar LD; Bethea CL
Neuroendocrinology; 1982 Oct; 35(4):225-30. PubMed ID: 7145018
[TBL] [Abstract][Full Text] [Related]
17. mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors.
Robertson DW; Bloomquist W; Wong DT; Cohen ML
Life Sci; 1992; 50(8):599-605. PubMed ID: 1736030
[TBL] [Abstract][Full Text] [Related]
18. The effects of quipazine on serotonin metabolism in rat brain.
Fuller RW; Snoddy HD; Perry KW; Roush BW; Molloy BB; Bymaster FP; Wong DT
Life Sci; 1976 May; 18(9):925-33. PubMed ID: 1271962
[No Abstract] [Full Text] [Related]
19. In vivo imaging of brain incorporation of fatty acids and of 2-deoxy-D-glucose demonstrates functional and structural neuroplastic effects of chronic unilateral visual deprivation in rats.
Wakabayashi S; Freed LM; Chang M; Rapoport SI
Brain Res; 1995 May; 679(1):110-22. PubMed ID: 7648253
[TBL] [Abstract][Full Text] [Related]
20. Effects of anesthesia and recovery from ketamine racemate and enantiomers on regional cerebral glucose metabolism in rats.
Freo U; Ori C
Anesthesiology; 2004 May; 100(5):1172-8. PubMed ID: 15114215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
